Key facts
- This page summarizes David Baxley Spetzler's Form 4 filing for Caris Life Sciences, Inc. (CAI).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 18 May 2026, 16:23.
David Baxley Spetzler - 15 May 2026 Form 4 Insider Report for Caris Life Sciences, Inc. (CAI)
- Reporting relationship
- President
- Issuer ticker
- CAI
- Reported as of
- 15 May 2026
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 18 May 2026, 16:23:15 UTC
- Prior SEC filing
- 10 Mar 2026
- Source filing
- View source filing
- Reporting owner signature
- /s/ J. Russel Denton, Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
David Baxley Spetzler filed Form 4 for Caris Life Sciences, Inc. (CAI) on 18 May 2026.
Change
- Previous filing in this sequence was filed on 10 Mar 2026.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0002071953
Primary reporting owner
Spetzler David Baxley
- Relationship
- President
- Address
- C/O CARIS LIFE SCIENCES, INC., 750 W. JOHN CARPENTER FREEWAY, SUITE 800, IRVING
- Signature
- /s/ J. Russel Denton, Attorney-in-Fact
- Signature date
- 18 May 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
CAI
transaction
Common Stock
Tax liability
- Transaction value
- Shares
- -13,856
- Change %
- -2.5%
- Price
- $15.25*
- Shares after
- 530,083
- Date
- 15 May 2026
- Ownership
- Direct
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
Shares withheld for the payment of taxes on the vesting and settlement of RSUs.
SEC remarks
President